nature neurOSCIenCe a r t I C l e S Human brain development is orchestrated by complex transcriptional programs 1 , which are guided and reinforced by epigenetic modifications to DNA and histone proteins. DNA methylation is the most extensively studied epigenetic modification, having a key role in many important genomic regulatory processes 2 . Of note, the establishment and maintenance of cell-and tissue-specific DNA methylation patterns is crucial for normal mammalian development 3 . Although traditionally regarded as a mechanism of transcriptional repression, DNA methylation can be associated with both increases and decreases in gene expression 4 , and has recently been implicated in other genomic functions, including alternative splicing and promoter usage 5 .
a r t I C l e S Human brain development is orchestrated by complex transcriptional programs 1 , which are guided and reinforced by epigenetic modifications to DNA and histone proteins. DNA methylation is the most extensively studied epigenetic modification, having a key role in many important genomic regulatory processes 2 . Of note, the establishment and maintenance of cell-and tissue-specific DNA methylation patterns is crucial for normal mammalian development 3 . Although traditionally regarded as a mechanism of transcriptional repression, DNA methylation can be associated with both increases and decreases in gene expression 4 , and has recently been implicated in other genomic functions, including alternative splicing and promoter usage 5 .
We recently characterized widespread changes in DNA methylation across human fetal brain development 6 , although the factors influencing inter-individual methylomic variation during the prenatal period are unknown. Studies in a variety of tissues, including adult human brain 7, 8 , have shown that DNA methylation can be influenced by DNA sequence variation. These mQTLs have been found to overlap with DNA variants associated with levels of gene expression (expression quantitative trait loci, eQTLs) 4, 9 , and may serve as markers for these as well as other genetic influences on gene regulation. Although mQTLs have been assessed in the adult human brain using low-resolution DNA methylation arrays 7, 8 , mQTLs in the developing human brain have not been explored.
We combined high-density DNA methylation profiling with genome-wide SNP genotyping in a large (n = 166) collection of human brain samples from the first and second trimester of gestation.
Given the growing evidence that many common variants associated with complex diseases act through effects on gene regulation 10 ,11 , we subsequently tested for enrichment of fetal mQTL among risk loci identified in a recent large-scale GWAS of schizophrenia 12 , a neuropsychiatric disorder with a hypothesized neurodevelopmental component 13, 14 . Finally, we found that mQTL data can be used to refine broad GWAS loci through the identification of discrete sites of variable fetal brain methylation associated with schizophrenia risk variants. As a resource to the wider community, we have developed a searchable online database of fetal brain mQTLs that can be accessed at http://epigenetics.essex.ac.uk/mQTL/. RESULTS mQTLs in the developing human brain are widespread and predominantly characterized by cis effects We performed genome-wide single-nucleotide polymorphism (SNP) genotyping and DNA methylation profiling in 166 human fetal brain samples ranging from 56-166 d post-conception (Online Methods and Supplementary Table 1) . After stringent quality control, we tested for an additive effect of allele dosage on DNA methylation across all potential pairings of 430,304 SNPs and 314,554 DNA methylation sites to identify fetal brain mQTLs (Supplementary Table 1) . We identified 16,809 mQTLs at a conservative Bonferronicorrected significance threshold of P < 3.69 × 10 −13 ( Supplementary  Tables 2 and 3) . The median DNA methylation change per allele across all identified mQTLs was 6.69% (interquartile range a r t I C l e S (IQR) = 3.17-8.96%) for each mQTL SNP (Supplementary Fig. 1 ), slightly larger than reported in a previous analysis of genome-wide mQTLs in the adult brain (median effect size = 4.11%, IQR = 2.13-6.97%) 7 . The majority of mQTL SNPs (74.17%) are associated with DNA methylation at only a single probe; in contrast, most DNA methylation sites (69.83%) showing evidence for association do so with multiple mQTL SNPs, presumably as a result of linkage disequilibrium (LD) between SNPs (Supplementary Fig. 2) . A searchable database of fetal brain mQTLs is available at http://epigenetics.essex. ac.uk/mQTL/.
The majority of fetal brain mQTLs (96.3%) involve SNPs and DNA methylation sites on the same chromosome ( Fig. 1a and Supplementary Table 2) . We defined significant SNP-methylation relationships spanning <500 kb as cis-mQTLs (n = 15,942, 94.8% of total), with those spanning >500 kb or being characterized by inter-chromosomal effects (n = 867, 5.16% of total) as representing trans-mQTLs. The strong enrichment of cis-mQTLs concurred with data from other tissues and cell types 7, [15] [16] [17] [18] . Among the cis-mQTLs, both effect size (that is, DNA methylation change per allele; Fig. 1b ) and significance (that is, P value; Supplementary  Fig. 3 ) were related to the distance between the Illumina 450K array probe and mQTL SNP.
Despite the preponderance of cis-mQTLs, there were some notable trans-mQTL effects ( Fig. 1c and Supplementary Table 4) , consistent with previous reports of long-range genetic regulation of epigenetic variation in multiple cell types 19 . Although the average effect size for trans-mQTLs was significantly lower than that observed for cis-mQTLs (two-sided Wilcoxon rank sum test, P = 6.74 × 10 −7 ; Supplementary Fig. 1 ), there was a higher proportion of larger (DNA methylation change per allele > 25%) effects among trans-mQTLs npg a r t I C l e S than cis-mQTLs (1.04% versus 0.715%). Of the 178 DNA methylation sites identified as being associated with trans-acting genetic variation in the fetal brain, 50 (28.09%) and 108 (60.67%) were also identified in studies of pancreatic islet cells 16 and lymphocytes 19 Table 7) , consistent with the observation that intermediately methylated domains, one potential consequence of allele-specific DNA methylation, are enriched in DHSs 25 . We also identified a significant enrichment of genotype-associated DNA methylation sites overlapping annotated transcription factor binding sites identified by the ENCODE project 10, 22 (relative enrichment = 1.26, P = 2.96 × 10 −11 ; Supplementary Table 8 ). Of note, there was a highly significant enrichment (odds ratio = 1.35, P = 1.66 × 10 −9 ) of fetal brain mQTLs influencing DNA methylation in CCCTCbinding factor (CTCF) motifs (Supplementary Table 8) , confirming a finding from a previous study of heritable DNA methylation sites in the human brain 26 . CTCF is an 11 zinc-finger protein with insulator and chromatin barrier activity whose binding affinity is known to be strongly influenced by DNA methylation 27 . Given the important role of CTCF in core genomic processes, including transcription, chromosomal interactions and chromatin structure 28 , the enrichment of genetically mediated DNA methylation at CTCF binding sites highlights an important potential mechanism linking genetic variation to genomic function. In addition to CTCF, a significant enrichment was also observed in binding sites for several other transcription factors, including IRF1 (relative enrichment = 1.34, P = 1.12 × 10 −6 ), GABP (relative enrichment = 1.32, P = 2.99 × 10 −6 ), ELF1 (relative enrichment = 1.26, P = 6.07 × 10 −6 ), Rad21 (relative enrichment = 1.31, P = 0.000133) and CCNT2 (relative enrichment = 1.25, P = 0.000298), with significant depletion in binding sites for others (for example, SUZ12 (relative enrichment = 0.350, P = 1.88 × 10 −9 ) and CtBP2 (relative enrichment 0.444, P = 0.000201); Supplementary Table 8) .
Although the majority of fetal brain mQTLs are conserved in adult brain regions, there are fetal-specific genetic effects on DNA methylation at certain loci We next generated mQTL data from three adult human brain regions (prefrontal cortex (PFC), striatum (STR) and cerebellum (CER)) Different significance thresholds were used to classify SNP associations from a recent large GWAS analysis of schizophrenia 12 . Empirical P values were derived by comparing 1,000,000 simulated SNP sets, matched for allele frequency. There was an enrichment of schizophrenia-associated variants among fetal brain mQTLs at all tested GWAS significance thresholds. No enrichment of fetal brain mQTLs was observed in similar-sized GWAS analyses of Alzheimer's disease 32 , body mass index 33 and T2D 34 . npg a r t I C l e S of 1,042 variants associated with 315 DNA methylation probes and 183 transcript probes. A list of all variants associated with both DNA methylation and gene expression in cis is given in Supplementary  Table 13 . This overlapping set of variants likely includes multiple SNPs in LD that are associated with one gene expression transcript and DNA methylation site. Because the extent and magnitude of LD varies across the genome, we established an LD-independent set of SNPs associated with DNA methylation and tested the overlap of these with the sentinelized subsignals, that is, the most associated marker from a set in high LD (r 2 > 0.8), from the brain eQTL data set 29 .
Compared with 1,000,000 simulated mQTL SNP sets matched for allele frequency, this overlap was significantly greater than expected (relative enrichment = 4.23, P < 1.00 × 10 −6 after 1,000,000 simulations; Supplementary Table 14 and Supplementary Fig. 8 ).
There is a significant enrichment of schizophrenia-associated GWAS variants in fetal brain mQTLs Our catalog of fetal brain mQTLs provides a unique resource for investigating putative functional consequences of genetic variation associated with postulated neurodevelopmental disorders such as schizophrenia. A recent large-scale GWAS identified 108 independent genomic loci exhibiting genome-wide significant association with the disorder (P < 5 × 10 −8 ), with evidence for a substantial polygenic component in signals that fall below this stringent level of significance 12 .
Because the majority of these variants reside in regions of strong LD and do not index coding variants affecting protein structure, there remains considerable uncertainty about the causal genes involved in pathogenesis and the way in which they are functionally regulated by schizophrenia risk variants. We used PLINK 30 to 'clump' our list of significant (P < 3.69 × 10 −13 ) fetal brain mQTL variants into a set of quasi-independent SNPs (SNP pairwise r 2 < 0.25 in 250 kb (non-major histocompatibility complex, MHC) or 10,000 kb (MHC); see Online Methods) and tested for enrichment of schizophreniaassociated variants across a range of GWAS significance thresholds, using up to 1,000,000 simulated SNP sets to generate empirical P values (Online Methods). We observed a highly significant enrichment (relative enrichment = 4.11, P = 3.0 × 10 −6 ) of genome-wide significant schizophrenia risk variants amongst fetal brain mQTLs, with a trend for stronger enrichment at more stringent levels of GWAS significance ( Supplementary Fig. 9 and Table 1 ). To examine the specificity of any enrichment, we repeated these analyses using large GWAS data sets from a non-neurodevelopmental brain disorder (Alzheimer's disease, AD 31 ) and two non-neurological phenotypes (body mass index, BMI 32 , and type 2 diabetes, T2D 33 ). Although our confidence in the enrichment of fetal brain mQTL in these data sets is limited by the smaller number of semi-independent GWAS SNPs, dissected from matched donors (n = 83; 21-96 years old; Online Methods and Supplementary Table 1 ) to explore the extent to which fetal brain mQTLs are also present in the adult brain. Using a replication mQTL significance threshold of P < 10 −5 , we found that the majority (83.46%) of fetal brain mQTLs were present in at least one of the tested adult brain region (Supplementary Table 9 and Fig. 2a ) and there was a highly significant overall correlation of individual mQTL effect sizes between fetal brain and each of the individual adult brain regions (PFC: r = 0.911, P < 2.2 × 10 −16 ; STR: r = 0.899, P < 2.2 × 10 −16 ; CER: r = 0.835, P < 2.2 × 10 −16 ; Supplementary  Fig. 4 ) across all Bonferroni-significant fetal brain mQTLs, even in mQTLs that did not meet our replication threshold ( Supplementary  Fig. 5 ). Of note, fetal brain mQTLs that did not replicate in adult brain were characterized by significantly lower effect sizes across all brain regions, including the fetal brain discovery sample (P = 3.18 × 10 −141 ; Supplementary Fig. 6 ). Despite the overall strong concordance in the direction of mQTL effects between fetal and adult brain, there are notable examples of heterogeneity between fetal and adult brain tissue. We used a multilevel linear regression model to test the significance of an interaction term and identify differential mQTL effects across our data sets. Of the 10,663 fetal mQTL effects that we tested, 3,173 (29.76%) were significantly heterogeneous (Bonferroni-corrected, P < 4.69 × 10 −6 ) across the fetal and adult data sets (Supplementary Table 10 ). These include mQTLs that had notably larger or smaller effects in the adult brain, and fetal-specific mQTLs showing no significant association with DNA methylation in any adult brain region (Fig. 2b) . We also identified a small number (n = 45) of fetal brain mQTLs that had opposite effects on DNA methylation in fetal and adult brain samples ( Fig. 2c and Supplementary Table 11 ).
Fetal brain mQTLs overlap with genetic variants associated with RNA transcript abundance in the brain
We used eQTL data from ten adult brain regions 29 to test whether identified fetal brain mQTLs overlap with genetic variants associated with RNA transcript abundance in cis. We compared the distribution of the minimum brain eQTL P values of all interrogated SNPs split into the subsets of those identified as fetal brain mQTLs and those that were not (Supplementary Fig. 7) , finding that variants associated with DNA methylation were indeed more likely to be associated with gene expression in cis (Wilcoxon rank-sum test P < 2.2 × 10 −16 ). Of the 414,172 SNPs tested in both the mQTL and eQTL data sets, 9,869 were identified as being Bonferroni-significant cis mQTLs and 2,674 as being Bonferroni-significant (P < 5.99 × 10 −9 ) eQTLs, with an overlap of 750 variants associated with 227 DNA methylation probes and 127 transcript probes (Supplementary Table 12 ). At a more relaxed eQTL threshold (P < 1.00 × 10 −7 ), there was an overlap npg a r t I C l e S levels of enrichment were found to be notably lower for all other tested phenotypes ( Table 1) . Variants associated with AD were, however, nominally significantly enriched at the most relaxed GWAS threshold (GWAS threshold P < 5 × 10 −5 : relative enrichment = 3.18, P = 0.022) and several individual GWAS variants identified for this and the other tested phenotypes were also significant mQTLs in fetal brain mQTLs (P < 3.69 × 10 −13 ; Supplementary Table 15 ).
The identified mQTLs residing in schizophrenia-associated GWAS regions do not necessarily represent the actual causal risk variants; in many instances, we are likely to be capturing 'passenger' effects whereby the variant influencing DNA methylation and the schizophrenia-associated SNP are instead co-segregating in the same LD block. Thus, we sought to identify instances in which a likely causal risk variant for schizophrenia was an mQTL SNP. We used data from the 1000 Genomes Project (http://www.1000genomes.org/) to identify all variants in strong LD (r 2 > 0.8) with the 125 autosomal index SNPs associated with schizophrenia 12 . Of note, two of the actual schizophrenia GWAS index SNPs represented Bonferroni-significant fetal brain mQTLs: rs2535627 (associated with DNA methylation at cg11645453, P = 3.05 × 10 −13 ; Supplementary Fig. 10 ) and rs4648845 (associated with DNA methylation at cg02275930, P = 4.54 × 10 −15 ; Supplementary Fig. 11 ). 46 additional mQTL variants that were in strong LD with another six index SNPs were part of 86 highly significant fetal brain mQTL pairs (Supplementary Table 16 ). mQTLs can be used to localize putative causal loci within large genomic regions associated with schizophrenia To generate a more comprehensive database of mQTLs in the fetal brain and to identify more examples in which the same SNP is associated with both DNA methylation and disease, we imputed our genotype data using the most recent panel downloaded from the 1000 Genomes Project (Online Methods). Using an imputed set of 5,177,320 variants, we identified an additional 256,040 mQTLs, which reflected the non-imputed data set in terms of genomic distribution and observed effect sizes (Supplementary Table 2 and Supplementary Fig. 12 ). The full list of fetal brain mQTLs after imputation can be downloaded from http://epigenetics.essex.ac.uk/ mQTL//All_Imputed_BonfSignificant_mQTLs.csv.gz. Our imputed data enabled us to identify 1,067 instances in which the same SNP was associated with both DNA methylation and schizophrenia, with a comprehensive list available for download at http://epigenetics. essex.ac.uk/mQTL//PGC_IndexSNPs_QTLs_Inc2PCs_AllTissues_ MatchSNPPosition.csv. Because they could be biased by the LD structure at associated loci, the imputed mQTL data were not used for subsequent enrichment analyses, but they enabled us to further refine schizophrenia candidate regions and undertake colocalization analyses to identify variants associated with both DNA methylation and schizophrenia. We performed a Bayesian colocalization analysis 34 across the 105 autosomal regions associated with schizophrenia 12 , spanning 19,378 DNA methylation sites included in our analysis.
Instead of focusing only on the intersection of significant variants associated with two phenotypes independently, this approach compares the pattern of association results from the schizophrenia GWAS and mQTL analyses across a region, combining the summary statistics into posterior probabilities for five hypotheses (Online Methods). As this methodology assumes that the causal variant is present, or at least very well tagged, in the data set, these colocalization analyses were performed using our imputed fetal brain mQTL data set. The posterior probabilities for 65 regions, involving 296 DNA methylation sites in 306 pairs, were supportive of a colocalized association signal for both schizophrenia and DNA methylation in that region (PP3+PP4 > 0.99; Supplementary Table 17) . 26 of these pairs (covering 15 regions associated with schizophrenia) had a higher Table 16 ), we compared effect sizes between fetal and adult brain. Effect sizes (red to blue) for the corresponding mQTLs in adult brain were significantly lower across all three adult brain regions tested (Wilcoxon rank-sum test: PFC P = 0.0420, STR P = 0.00226, CER P = 0.00998). The heterogeneity P value for each mQTL is depicted by the green (high heterogeneity) to yellow (low heterogeneity) column. White indicates that the mQTL was not tested in the adult brain samples.
npg a r t I C l e S posterior probability for both schizophrenia and DNA methylation being associated with the same causal variant (PP 4 /PP 3 > 1), with 16 (10 regions) of these having sufficient support for them to be considered as 'convincing' (PP 4 /PP 3 > 5) according to the criteria of a previous study 34 . Of note, three of these top-ranked pairs were annotated to the AS3MT locus in a robust schizophrenia-associated region on chromosome 10 (Supplementary Table 17 ). The utility of mQTL mapping for localizing putative causal loci associated with disease in this region is shown in Figure 3 , with additional examples for other schizophrenia-associated regions available on our website (http://epigenetics.essex.ac.uk/mQTL/).
Schizophrenia-associated genomic regions are enriched for fetal-specific mQTLs Given the hypothesized neurodevelopmental component to schizophrenia, we examined the extent to which the mQTLs overlapping with schizophrenia-associated variants are characterized by fetalspecific effects (Supplementary Table 16 ). Across the 78 mQTLs also tested in adult brain samples, overall effect sizes were significantly larger in fetal brain than all of the adult brain regions tested (Wilcoxon rank-sum test: PFC P = 0.0420, STR P = 0.00226, CER P = 0.00998; Fig. 4 ). Our heterogeneity analysis highlighted 16 (20.5%) instances in which significantly different relationships between genotype and DNA methylation were found across the adult and fetal data sets, with eight classed as fetal-specific variants (that is, those not reaching our replication threshold (P < 1.00 × 10 −5 ) in any adult brain region) and the remaining eight demonstrating smaller effects across the adult brain.
DISCUSSION
To explore the functional consequences of genetic variation in the developing human brain, we characterized mQTLs in human fetal brain samples (spanning 56-166 d post-conception), identifying over 16,000 associated pairs of SNPs and DNA methylation sites. We found that fetal brain mQTLs were significantly enriched in functional regulatory domains, including DHSs, regions of repressive histone modifications and specific transcription factor binding sites across the genome, and observed significant overlap with genetic variants influencing gene expression in the brain. Although the majority of fetal brain mQTLs appear to be conserved across adult brain regions, we found evidence for fetal-specific genetic effects at certain loci. Our data concur with findings from an independent study of cortical mQTLs across development 35 ; mQTL effects were highly consistent across both analyses (Supplementary Fig. 13 ) and largely conserved between fetal and adult brain. There is growing evidence that the majority of common variants associated with complex traits act through effects on gene regulation 10, 11 . Our data add to a growing literature showing that DNA methylation is genetically influenced 26 , with mQTLs representing a potential mechanism linking genetic variation to complex phenotypes 4, 9, 36, 37 . We found a significant enrichment of schizophrenia-associated GWAS variants in fetal brain mQTLs, indicating that common genetic variants conferring risk for schizophrenia are associated with altered DNA methylation in fetal human brain. The hypothesis that schizophrenia has an early neurodevelopmental component is supported by several lines of epidemiological and neuropathological evidence 13, 14 . However, direct molecular evidence of schizophrenia risk factors operating in the fetal brain is scarce 38, 39 . We recently found that genomic loci that are differentially methylated between schizophrenia patients and unaffected controls in the adult brain are enriched at those undergoing dynamic changes in DNA methylation during human fetal brain development 6, 40 . Here we found that genetic variants exhibiting genome-wide significant association with schizophrenia 12 showed a fourfold enrichment amongst fetal brain mQTLs, directly implicating altered gene regulation during fetal brain development in the etiology of the disorder.
To conclude, we report, to the best of our knowledge, the first systematic analysis of genetically mediated DNA methylation in the developing human brain. Our data support the hypothesis that a substantial proportion of the genetic variants conferring schizophrenia risk have regulatory effects that become manifest early in the prenatal period and demonstrate the utility of mQTL mapping for localizing putative causal loci associated with complex disease phenotypes in large genomic regions. As a resource to the wider community, we have developed a searchable online database of fetal brain mQTLs that can be accessed at http://epigenetics.essex.ac.uk/mQTL/.
METhODS
Methods and any associated references are available in the online version of the paper. 
